Scholars Central

Conference abstractPublished 10 Aug 2016

Can we use alternative tumor size criteria in T3 sub-classification of pancreas head cancer?

Authors: Sangjeong Ahn, Kee-Taek Jang

Pusan National University Hospital, South Korea Pusan National University, South Korea Samsung Medical Center, South Korea Sungkyunkwan University School of Medicine, South Korea

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Pathologic tumor staging is the most powerful predictor. However tumor staging of pancreatic cancer has been known to be less predictive because most surgically resected pancreatic cancer corresponds to T3. We hypothesized current T3 included wide range of cases and suspected tumor size can be useful parameter to induce alternative pathologic T3 sub-staging system. Method: We reviewed surgically resected 151 pancreatic head cancer cases during 2006~2009. The receiver operating characteristic curve was used to verity that tumor size is a superior predictor of survival to pT stage. Further a recursive partitioning technique with the log-rank test was used to identify a significant cutoff value for the sub-staging of tumor size of pancreas head cancer using. Result: Among total 151 cases, 2 cases were staged as T2 (1.3%), 148 cases as T3 (96.1%) and 4 cases as T4 (2.6%), respectively. The mean size of tumor was 3.0 cm, ranging 1.4~6.0 cm. ROC curve analysis revealed that tumor size reflects patients survival better than current pT stage of AJCC 7th edition (AUC=0.707, P=0.001; AUC=0.530, P=0.626). The cutoff value of tumor size was 2.4 cm and 3.6 cm, which segregated patients into 3 groups: Each group with statistically significant decreasing length of median survival (P<0.001). Conclusion: We found tumor size cutoff value 2.4 cm and 3.6 cm could be an alternative size criteria in sub-classification of pathologic T3 pancreatic head carcinoma. Here we propose an alternative size criterion in T sub-classification of pancreas head cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cytology & Histology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Sangjeong Ahn”
  • BylineArticles whose byline prints “Kee-Taek Jang”